For patients with early Alzheimer’s disease, lecanemab reduced markers of amyloid and resulted in moderately less decline in cognition and function at 18 months, according…
It is estimated that some one million Australians are living with mild cognitive impairment. It’s a startling number, but leading geriatrician Associate Professor Michael Woodward,…
A GP who forged a patient’s signature to access her hospital records has failed to convince a tribunal that a cardiac condition explained his “mentally erratic”…
Australian researchers are examining the potential link between nose picking or plucking nasal hairs and dementia. Griffith University researchers have proven that the Chlamydia pneumoniae…
Boxing legend Muhammad Ali’s prominent neurological symptoms — namely, the left-arm rest tremor — were not the result of boxing-related head trauma, his doctors have…
Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease. These are very promising results, although the only data…
GPs are being urged to prescribe physical activity, memory strategies training and optimal nutrition to patients under Australia’s first expert recommendations for mild cognitive impairment.…
People diagnosed with dementia under the age of 65 have a near threefold increased risk of suicide than those without the neurodegenerative condition, a population-based…
An experimental dementia drug that targets beta-amyloid has shown potential for slowing cognitive decline in the early stages of Alzheimer’s, drug-makers say. The agent, lecanemab,…
It aims to help home and community support workers better understand people living with dementia.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
